Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-centre Randomised Adaptive Platform Clinical Trial to Assess Clinical, Virological and Immunological Outcomes in Patients With SARS-CoV-2 Infection (COVID-19)

NCT04483960 is registered in ClinicalTrials.gov with University of Melbourne as lead sponsor.

NCT NCT04483960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04483960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-centre Randomised Adaptive Platform Clinical Trial to Assess Clinical, Virological and Immunological Outcomes in Patients With SARS-CoV-2 Infection (COVID-19)
Lead sponsor
University of Melbourne
Phase
Phase 3
Overall status
Unknown status
Start date
July 28, 2020
Completion date
December 31, 2025
Enrollment
2,200 (estimated)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2 infection (covid-19)